Goldline Pharmaceutical Ltd
Statement of profit and loss
Parakho has not ingested a filed result for this company on a consolidated basis. When the company files one with the exchange, it appears here automatically.
Earnings call
Goldline Pharmaceutical Ltd has not filed a concall transcript in the last 4 quarters.
Filings
12 shown · 27 published by the exchange
12 Oct 2026
24 Sept 2026
Insider trading02 Sept 2026
Insider tradingDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Appears 2 times in the recent filings shown; listed once.
01 Sept 2026
31 Aug 2026
29 Aug 2026
29 Aug 2026
Insider tradingDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
Appears 2 times in the recent filings shown; listed once.
07 Aug 2026
Filing06 Aug 2026
06 Aug 2026
06 Aug 2026
06 Aug 2026
BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.
Industry
Healthcare › Pharmaceuticals
Classification as published by BSE.
Companies also in Pharmaceuticals, in alphabetical order
Page generated from filings held to 12 Oct 2026.